Australia wants to keep "rule of origin" in MRA (Mutual Recognition Agreement):
This article was originally published in Clinica
A new hurdle has emerged in the Mutual Recognition Agreement between Australia and the EU. The Australian delegation wants to keep the so-called "rule of origin" in the MRA, meaning that the MRA could not be applied to manufacturers based outside Australia or Europe. Rules of origin are difficult to police and the EU has a tendency to drop them from such MRA agreements. The issue is currently being discussed within the European Commission's Directorate General Trade.
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.